Prednisone Terminated Phase 2 Trials for Follicular Lymphoma, Grade 3b / Transformed Lymphoma / DLBCL / Lymphoma, Large B-Cell, Diffuse (DLBCL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02855359Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
NCT02531308Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)